These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

645 related items for PubMed ID: 12133653

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure.
    Duman D, Palit F, Simsek E, Bilgehan K, Sacide A.
    Can J Cardiol; 2009 Oct; 25(10):e353-6. PubMed ID: 19812809
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure.
    Nieminen MS, Akkila J, Hasenfuss G, Kleber FX, Lehtonen LA, Mitrovic V, Nyquist O, Remme WJ.
    J Am Coll Cardiol; 2000 Nov 15; 36(6):1903-12. PubMed ID: 11092663
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A comparison of dobutamine and levosimendan on hepatic blood flow in patients with a low cardiac output state after cardiac surgery: a randomised controlled study.
    Alvarez J, Baluja A, Selas S, Otero P, Rial M, Veiras S, Caruezo V, Taboada M, Rodriguez I, Castroagudin J, Tome S, Rodriguez A, Rodriguez J.
    Anaesth Intensive Care; 2013 Nov 15; 41(6):719-27. PubMed ID: 24180712
    [Abstract] [Full Text] [Related]

  • 28. Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE.
    Mebazaa A, Nieminen MS, Filippatos GS, Cleland JG, Salon JE, Thakkar R, Padley RJ, Huang B, Cohen-Solal A.
    Eur J Heart Fail; 2009 Mar 15; 11(3):304-11. PubMed ID: 19158152
    [Abstract] [Full Text] [Related]

  • 29. Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
    Cholley B, Caruba T, Grosjean S, Amour J, Ouattara A, Villacorta J, Miguet B, Guinet P, Lévy F, Squara P, Aït Hamou N, Carillion A, Boyer J, Boughenou MF, Rosier S, Robin E, Radutoiu M, Durand M, Guidon C, Desebbe O, Charles-Nelson A, Menasché P, Rozec B, Girard C, Fellahi JL, Pirracchio R, Chatellier G, -.
    JAMA; 2017 Aug 08; 318(6):548-556. PubMed ID: 28787507
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.
    Morelli A, De Castro S, Teboul JL, Singer M, Rocco M, Conti G, De Luca L, Di Angelantonio E, Orecchioni A, Pandian NG, Pietropaoli P.
    Intensive Care Med; 2005 May 08; 31(5):638-44. PubMed ID: 15812624
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.
    Hummel J, Rücker G, Stiller B.
    Cochrane Database Syst Rev; 2017 Mar 06; 3(3):CD011312. PubMed ID: 28262914
    [Abstract] [Full Text] [Related]

  • 34. Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction.
    Huang L, Weil MH, Tang W, Sun S, Wang J.
    Crit Care Med; 2005 Mar 06; 33(3):487-91. PubMed ID: 15753736
    [Abstract] [Full Text] [Related]

  • 35. Levosimendan: a new inodilatory drug for the treatment of decompensated heart failure.
    Kivikko M, Lehtonen L.
    Curr Pharm Des; 2005 Mar 06; 11(4):435-55. PubMed ID: 15725064
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Therapy of acute decompensated heart failure with levosimendan].
    Müller K, Peters A, Zeus T, Hennersdorf M, Strauer BE.
    Med Klin (Munich); 2006 Mar 22; 101 Suppl 1():119-22. PubMed ID: 16802535
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S, Parissis JT, Iliodromitis EK, Paraskevaidis I, Tsiapras D, Farmakis D, Karatzas D, Gheorghiade M, Filippatos GS, Kremastinos DT.
    Am J Cardiol; 2006 Jul 01; 98(1):102-6. PubMed ID: 16784930
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.